Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
amgen
2
×
biotech
boston blog main
boston top stories
2
×
clinical trials
life sciences
national blog main
national top stories
new york blog main
2
×
new york top stories
novartis
the medicines company
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alirocumab
alopecia areata
amarin
aridis pharmaceuticals
aristea therapeutics
autoimmune diseases
axitinib
bellus health
biotech ipos
bolt biotherapeutics
boulder/denver blog main
boulder/denver top stories
bridgebio
bristol-myers squibb
cancer
cell therapy
cidara therapeutics
cigna
concert pharmaceuticals
cvs health
deals
What
brings
2
×
drug
new
acquire
advantages
agreed
bar
billion
bio
cash
cholesterol
company
compound
deal
expect
fda
gamble
market
medco
medco’s
medicines
mover
novartis
patients
payers
physicians
plan
poised
pricing
ready
roundup
sets
type
ubiome
undone
vertex’s
wave
Language
unset
Current search:
brings
×
amgen
×
" boston top stories "
×
" new york blog main "
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone